Exicure, Inc. Files 8-K/A with Financials
Ticker: XCUR · Form: 8-K/A · Filed: Jan 23, 2025 · CIK: 1698530
| Field | Detail |
|---|---|
| Company | Exicure, Inc. (XCUR) |
| Form Type | 8-K/A |
| Filed Date | Jan 23, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, amendment, exhibits
Related Tickers: XCUR
TL;DR
Exicure (XCUR) filed an 8-K/A on Jan 23, 2025, with updated financials. Check it out.
AI Summary
Exicure, Inc. filed an 8-K/A on January 23, 2025, to report financial statements and exhibits. This filing amends a previous report and provides updated information regarding the company's financial status and operational disclosures. The company, formerly known as Max-1 Acquisition Corp, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides updated financial information for Exicure, Inc., which is crucial for investors to assess the company's current financial health and performance.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and exhibits, not indicating any immediate operational or financial distress.
Key Numbers
- 001-39011 — SEC File Number (Identifies the company's filing with the SEC)
- 81-5333008 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Exicure, Inc. (company) — Registrant
- Max-1 Acquisition Corp (company) — Former company name
- January 23, 2025 (date) — Date of earliest event reported
- 2430 N. Halsted St. Chicago, IL 60614 (address) — Principal executive offices
- 847-673-1700 (phone_number) — Registrant's telephone number
FAQ
What is the purpose of this 8-K/A filing?
The purpose of this 8-K/A filing is to report financial statements and exhibits as of January 23, 2025.
What was Exicure, Inc.'s former name?
Exicure, Inc. was formerly known as Max-1 Acquisition Corp.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on January 23, 2025.
What is Exicure, Inc.'s principal executive office address?
Exicure, Inc.'s principal executive office is located at 2430 N. Halsted St., Chicago, IL 60614.
What is Exicure, Inc.'s industry classification?
Exicure, Inc. is classified under Pharmaceutical Preparations [2834].
Filing Stats: 434 words · 2 min read · ~1 pages · Grade level 10.1 · Accepted 2025-01-23 07:58:33
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share XCUR The Nasdaq Stock Market
Filing Documents
- xcur-20250123.htm (8-K/A) — 24KB
- ex991pressrelease12325.htm (EX-99.1) — 15KB
- exicureimage1a10.gif (GRAPHIC) — 3KB
- 0001698530-25-000006.txt ( ) — 170KB
- xcur-20250123.xsd (EX-101.SCH) — 2KB
- xcur-20250123_lab.xml (EX-101.LAB) — 22KB
- xcur-20250123_pre.xml (EX-101.PRE) — 13KB
- xcur-20250123_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release dated January 23, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 23, 2025 EXICURE, INC. By: /s/ Andy Yoo Andy Yoo Chief Executive Officer